Clinical Trials Directory

Trials / Conditions / Recurrent Skin Cancer

Recurrent Skin Cancer

11 registered clinical trials studyying Recurrent Skin Cancer.

StatusTrialSponsorPhase
TerminatedPilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma
NCT02303041
Anne ChangPhase 2
CompletedCetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
NCT02324608
Rutgers, The State University of New JerseyN/A
CompletedArsenic Trioxide in Treating Patients With Basal Cell Carcinoma
NCT01791894
Stanford UniversityPhase 1 / Phase 2
TerminatedCapecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin
NCT01823679
Stanford UniversityPhase 2
CompletedVismodegib in Treating Patients With Basal Cell Carcinoma (BCC)
NCT01631331
Stanford UniversityEARLY_Phase 1
WithdrawnIsolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
NCT02507076
Albert Einstein College of MedicineN/A
WithdrawnPhase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma
NCT01465815
OHSU Knight Cancer InstitutePhase 1 / Phase 2
CompletedPhotodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patie
NCT01292668
Roswell Park Cancer InstitutePhase 1
CompletedDasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chro
NCT00563290
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Rec
NCT00126555
National Cancer Institute (NCI)Phase 2
CompletedT4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a
NCT00089180
National Cancer Institute (NCI)Phase 2